|

Iron oxide nanoparticles.
Image: UC San Diego

These PC12 cells were exposed to no (left), low (center),
and high (right) concentrations of iron oxide nanoparticles in the
presence of nerve growth factor, which normally stimulates these
neuronal cells to form thread-like extensions called neurites.

Recent UC San Diego Ph.D. graduate Thomas R Pisanic, II (left) and
materials science professor Sungho Jin.
Images: UC San Diego
|
In their studies, the UCSD researchers used
PC12 cells, a line derived from a rat pheochromocytoma. Nerve growth
factor prompts PC12 cells to express a variety of neuron-specific
genes and generate thin sprout-like cellular extensions called
neurites, which are hundreds of times longer than the width of the
cell, or up to several millimeters in length. These properties of PC12
cells have made them useful for studying the neurobiological and
neurochemical properties of nerve cells.
Jin and the other co-authors of the paper, Thomas R
Pisanic, II, Jennifer D. Blackwell, Veronica Shubayev, and Rita
Finoņes began their laboratory experiments by coating iron oxide
nanoparticles with DMSA (dimercaptosuccinic acid), a metal binding
agent that polymerizes on the particles' surface. This coating keeps
the particles from clumping together in an aqueous solution, and
facilitates their engulfment by the PC12 cells via an inward pouching
of the cell membrane called endocytosis. What happened next was a
surprise.
Jin's group had initially investigated the
nanoparticles for use in in vitro studies as a possible way to
manipulate nerve cells remotely with magnetic force. Eventually they
had hoped to conduct in vivo experiments, using nanoparticles-laden
nerve cells to bridge regions of damaged neurons. However, when they
added nerve growth factor to nanoparticle-laden cells in culture
flasks, they observed toxic dose-dependent effects: some cells died,
and many of the survivors exhibited a diminished ability to produce
neurites.
In their experiments, PC12 cells that had not been
exposed to magnetic nanoparticles generated three neurites in response
to nerve growth factor. However, exposure to a low concentration of
iron oxide nanoparticles resulted in the production of fewer than
three neurites per cell in response to growth factor addition. A
10-fold increase in the concentration of nanoparticles led to the
production of two neurites per cell, and a 10-fold increase of that
concentration resulted in only one neurite per cell. Additionally,
neurites produced in response to the growth factor in the presence of
iron oxide nanoparticles were less well formed and also showed
abnormal morphology and neurobiological characteristics.
The researchers also studied long protein polymers
inside the PC12 cells that make up the cytoskeletal structure. They
found that iron oxide nanoparticles resulted in fewer and less
organized microtubules and microfilaments, protein polymers involved
in cell motility and cell shape.
"It's worth noting that neither iron oxide
nanoparticles alone, nor the coating material alone are overtly toxic,
but combining the two to create water-soluble nanoparticles has a
completely different effect," said Pisanic, who carried out the
studies as a part of a Ph.D. thesis project at UCSD.
Iron oxide nanoparticles are considered promising
because they are maneuverable by remote magnetic fields, and can be
coated with various marker molecules to make them stick selectively to
tumors and other targets within the body. The particles can also be
made to carry anti-cancer drugs or radioactive materials directly to a
tumor. Magnetic nanoparticles designed to attach to cancerous tissue
can also be made to heat up by using a remote, alternating magnetic
field, thereby selectively killing cancer cells in a process called
magnetic hyperthermia.
Many researchers throughout the world are also
studying the use of iron-containing nanoparticles in gene therapy,
magnetic resonance imaging (MRI), and other medically important
applications. While studies have focused primarily on the many
potential uses of nanoparticles, Jin said more attention should be
paid to their safety. "Our experience leads us to conclude that any
analysis of the biocompatibility of nanoparticles should include not
just a toxicological study of the component parts," said Pisanic, "but
also an examination of the total structure as a whole." |